Tata Motors Abridged LOF - Vfinal PDF
Tata Motors Abridged LOF - Vfinal PDF
Tata Motors Abridged LOF - Vfinal PDF
Tata Motors Limited was incorporated as Tata Locomotive and Engineering Company Limited on September 1, 1945 as a public limited liability company
under the Companies Act, 1913. For details in relation to change in name of our Company, see General Information on page 43 of the Letter of Offer.
Registered Office: Bombay House, 24, Homi Mody Street, Mumbai 400 001
Contact Person: H K Sethna, Company Secretary and Compliance Officer
Tel: (91 22) 6665 8282; Fax: (91 22) 6665 7799; Email: inv_rel@tatamotors.com; Website: www.tatamotors.com
Corporate Identity Number: L28920MH1945PLC004520
PROMOTER OF OUR COMPANY: TATA SONS LIMITED
FOR PRIVATE CIRCULATION TO THE ELIGIBLE SHAREHOLDERS OF
TATA MOTORS LIMITED (OUR COMPANY OR THE ISSUER) ONLY
SIMULTANEOUS BUT UNLINKED ISSUE OF UP TO 15,06,44,759 ORDINARY SHARES OF FACE VALUE ` 2 EACH (THE
ORDINARY SHARES) OF OUR COMPANY FOR CASH AT A PRICE OF ` 450 (INCLUDING A PREMIUM OF ` 448 PER
ORDINARY SHARE) ON A RIGHTS BASIS TO THE ELIGIBLE ORDINARY SHAREHOLDERS OF OUR COMPANY IN THE
RATIO OF SIX ORDINARY SHARES FOR 109 FULLY PAID-UP ORDINARY SHARES HELD ON THE BOOK CLOSURE DATE,
THAT IS ON APRIL 8, 2015 AND UP TO 2,65,30,290 A ORDINARY SHARES OF FACE VALUE ` 2 EACH (THE A ORDINARY
SHARES) OF OUR COMPANY FOR CASH AT A PRICE OF ` 271 (INCLUDING A PREMIUM OF ` 269 PER A ORDINARY
SHARE) ON A RIGHTS BASIS TO THE ELIGIBLE A ORDINARY SHAREHOLDERS OF OUR COMPANY IN THE RATIO
OF SIX A ORDINARY SHARES FOR 109 FULLY PAID-UP A ORDINARY SHARES HELD ON THE BOOK CLOSURE DATE,
THAT IS ON APRIL 8, 2015 (COLLECTIVELY, THE ISSUE). THE ISSUE PRICE OF THE ORDINARY SHARES IS 225 TIMES
THE FACE VALUE OF THE ORDINARY SHARES. THE ISSUE PRICE OF THE A ORDINARY SHARES IS 135.5 TIMES THE
FACE VALUE OF THE A ORDINARY SHARES. TOTAL PROCEEDS FROM THE ISSUE OF ORDINARY SHARES AND A
ORDINARY SHARES WOULD AGGREGATE UP TO ` 7,498 CRORE. FOR FURTHER DETAILS, SEE TERMS OF THE ISSUE
BEGINNING ON PAGE 157 OF THE LETTER OF OFFER.
GENERAL RISKS
Investment in equity and equity related securities involve a degree of risk and investors should not invest any funds in the Issue unless they can
afford to take the risk of losing their investment. Investors are advised to read the risk factors carefully before taking an investment decision in
the Issue. For taking an investment decision, investors must rely on their own examination of our Company and the Issue including the risks
involved. The securities being offered in the Issue have not been recommended or approved by the Securities and Exchange Board of India
(SEBI) nor does SEBI guarantee the accuracy or adequacy of the Letter of Offer. Investors are advised to refer to Risk Factors beginning
on page 15 of the Letter of Offer before making an investment in this Issue.
ISSUERS ABSOLUTE RESPONSIBILITY
Our Company, having made all reasonable inquiries, accepts responsibility for and confirms that the Letter of Offer contains all information with
regard to our Company and the Issue, which is material in the context of the Issue, that the information contained in the Letter of Offer is true
and correct in all material aspects and is not misleading in any material respect, that the opinions and intentions expressed herein are honestly
held and that there are no other facts, the omission of which makes the Letter of Offer as a whole or any such information or the expression of
any such opinions or intentions misleading in any material respect.
LISTING
The existing Ordinary Shares and A Ordinary Shares of our Company are listed on the BSE Limited (the BSE) and the National Stock
Exchange of India Limited (the NSE, and together with BSE, the Stock Exchanges). Our Company has received approvals from the BSE
and the NSE under Clause 24(a) of the Listing Agreement for listing the Securities to be allotted pursuant to the Issue through their letters, dated
March 27, 2015. For the purposes of the Issue, the Designated Stock Exchange is the BSE.
ISSUE OPENS ON
APRIL 17, 2015
ISSUE PROGRAMME
LAST DATE FOR REQUEST FOR
SPLIT APPLICATION FORMS
APRIL 24, 2015
1
ISSUE CLOSES ON
MAY 2, 2015
Legal Advisor to the GCSLMs, the Lead Managers and Co-Lead Manager as
to Indian law
AZB & Partners
24th Floor, Express Towers, Nariman Point, Mumbai 400 021
Tel: (91 22) 6639 6880; Fax: (91 22) 6639 6888
International Legal Advisor to our Company
Sullivan & Cromwell (Hong Kong)
28th Floor, Nine Queens Road Central, Hong Kong
Tel: (852) 2826 8688; Fax: (852) 2522 2280
International Legal Advisor to the GCSLMs, the Lead Managers and the CoLead Manager
Shearman and Sterling
12/F, Gloucester Tower, The Landmark, 15 Queens Road Central, Hong Kong
Tel: (852) 2978 8000; Fax: (852) 2978 8099
Statutory Auditor of our Company
Deloitte Haskins & Sells LLP
Indiabulls Finance Centre, 32nd Floor, Tower 3 Compound,
Elphinstone (W) Mumbai 400 013
Tel: (91 22) 6185 4000; Fax: (91 22) 6185 5380
Firm Registration Number: 117366W/W 100018
Appraising Entity
None of the purposes for which the Net Proceeds are proposed to be utilised have been
financially appraised by any banks or financial institution or any other independent agency.
For definitions and abbreviations, see Definitions and Abbreviations on page 2 of
the Letter of Offer.
Debenture trustee
This being an issue of Ordinary Shares and A Ordinary Shares, a debenture trustee
is not required.
Company Secretary and Compliance Officer
H K Sethna
Bombay House, 24, Homi Mody Street, Mumbai 400 001
Tel: (91 22) 6665 8282
Fax: (91 22) 6665 7799
E-mail: inv_rel@tatamotors.com
Monitoring Agency
Our Company has appointed HDFC Bank, as the monitoring agency to monitor the
utilization of the Net Proceeds in terms of Regulation 16 of the SEBI Regulations.
Issue Schedule
Issue Opening Date
Last date for receiving requests for SAFs
Issue Closing Date
Allotment Date (on or about)
Date of credit (on or about)
Date of listing (on or about)
:
:
:
:
:
:
TABLE OF CONTENTS(1)
SECTION
NOTICE TO INVESTORS
RISK FACTORS
THE ISSUE
SUMMARY FINANCIAL INFORMATION
CAPITAL STRUCTURE
OBJECTS OF THE ISSUE
OUR MANAGEMENT
RELATED PARTY TRANSACTIONS
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS
WORKING RESULTS
MATERIAL DEVELOPMENTS
OUTSTANDING LITIGATION AND DEFAULTS
GOVERNMENT AND OTHER APPROVALS
OTHER REGULATORY AND STATUTORY DISCLOSURES
TERMS OF THE ISSUE
MATERIAL CONTRACTS AND DOCUMENTS FOR INSPECTION
DECLARATION
PAGE NO.
4
4
17
18
26
33
40
44
44
57
57
59
61
61
66
86
88
(1) In terms of Regulations 58(2) read with paragraph (2) of Part F of Schedule VIII of the SEBI Regulations, the order in which
the sections (as applicable) appear in this Abridged Letter of Offer corresponds to the order in which such sections appear in the
Letter of Offer.
3
RISK FACTORS
An investment in the Securities involves a high degree of risk.
The risks described below together with other information
contained in the Letter of Offer should be carefully considered
by the prospective investors before making an investment
decision. The risks described below are not the only risks which
are relevant to our Company or investments in securities of
Indian issuers. Additional risks not presently known to us or
that we currently deem immaterial may also adversely affect
our business operations. Our business, financial condition or
results of operations could be materially and adversely affected
by any of these risks, the trading price of the Securities could
decline, and all or part of your investment may be lost. Unless
otherwise stated, we are not in a position to specify or quantify
the financial or other risks mentioned herein.
The Letter of Offer also contains forward-looking statements
that involve risks and uncertainties. Our actual results could
differ materially from those anticipated in these forwardlooking statements as a result of certain factors, including
the considerations described below and Forward Looking
Statements on page 13 of the Letter of Offer.
Risks arising out of Offences/Litigations/Losses
Nil
Company/Group Specific Risks
1. Restrictive covenants in our financing agreements may
limit our operations and financial flexibility and materially
and adversely impact our financial condition, results of
operations and prospects.
Some of our financing agreements and debt arrangements
set limits on or require us to obtain lender consent before,
among other things, pledging assets as security. In addition,
certain financial covenants may limit our ability to borrow
additional funds or to incur additional liens. In the past, we
have been able to obtain required lender consent for such
activities. However, there can be no assurance that we will
be able to obtain such consents in the future. If our liquidity
needs, or growth plans, require such consents and such
consents are not obtained, we may be forced to forego or
alter our plans, which could materially and adversely affect
our financial condition and results of operations.
In the event we breach financing agreements, the outstanding
amounts due thereunder could become due and payable
immediately or result in increased costs. A default under one
of these agreements may also result in cross- defaults under
other financing agreements and result in the outstanding
amounts under such other financing agreements becoming
due and payable immediately. This could have a material
adverse effect on our financial condition and results of
operations.
In recent years, we have been in breach of financial
covenants relating to our ratio of total outstanding liabilities
to tangible net worth and to our debt service coverage ratio
in various financing agreements. We requested and obtained
waivers of our obligations from our lenders and guarantors
to pay additional costs as a consequence of such breaches.
These breaches have not resulted in an event of default in
our financing agreements or the payment of penalties.
If we are in breach of these financials covenants in Fiscal
2015, we plan to seek consents or waivers from our lenders
or guarantors.
However, we cannot assure you that we will succeed in
obtaining consents or waivers in the future from our lenders
or guarantors, or that our lenders and guarantors will not
4
4.
5.
6.
5
11
Sr.
No.
14
Category of companies
First period of
reporting
1
Companies
whose Fiscal
Year
securities are either listed commencing on or
or proposed to list, on any after April 1, 2016
stock exchange in India or
outside India and having a
net worth of ` 500 crore or
more
2
Companies other than those Fiscal
Year
covered in (1) above and commencing on or
having a net worth of ` 500 after April 1, 2016
crore or more
3
Companies
whose Fiscal
Year
securities are either listed commencing on or
or proposed to list, on any after April 1, 2017
stock exchange in India or
outside India and having a
net worth of less than ` 500
crore
4
Unlisted companies having Fiscal
Year
a net worth of ` 250 crore commencing on or
or more but less than ` 500 after April 1, 2017
crore
In addition, any holding, subsidiary, joint venture or
associate companies of the companies specified above shall
also comply with such requirements from the respective
periods specified above.
There is not yet a significant body of established practice
on which to draw informing judgments regarding its
implementation and application. Additionally, Ind-AS
differs in certain respects from IFRS and therefore financial
statements prepared under Ind-AS may be substantially
different from financial statements prepared under IFRS.
There can be no assurance that our Companys financial
condition, results of operation, cash flow or changes in
shareholders equity will not be presented differently
under Ind-AS than under Indian GAAP or IFRS. When
16
by
Ordinary Shares
our Up to 15,06,44,759 Ordinary Shares
Issue Size
Securities outstanding prior to the Issue
Securities outstanding after the Issue
(assuming full subscription for and
Allotment of the Rights Entitlement)
Security Codes
A Ordinary Shares
Up to 2,65,30,290 A Ordinary Shares
Up to ` 6,779.01 crore
2,73,67,13,122 Ordinary Shares
Up to 2,88,73,57,881 Ordinary Shares(1)(2)
ISIN: INE155A01022
ISIN: IN9155A01020
BSE: 500570
BSE: 570001
NSE: TATAMOTORS
NSE: TATAMTRDVR
Terms of the Issue
For more information, see Terms of the Issue on page 157 of the Letter of Offer.
Use of Issue Proceeds
For further information, see Objects of the Issue on page 60 of the Letter of Offer.
(1) The call money in respect of 13,746 ordinary shares of our Company of face value ` 10 each is currently outstanding. For
further details, see Capital Structure on page 51 of the Letter of Offer.
(2) The entitlements to 4,84,470 Ordinary Shares and 2,39,570 A Ordinary Shares are subject matters of various suits filed in the
courts / forums by third party for which final order is awaited and hence kept in abeyance.
(3) The Securities have not been and will not be registered under the Securities Act, and may not be offered or sold within the
United States or to US persons except in transactions not requiring registration thereunder. Any CAFs bearing an address in
the United States will not be accepted.
Our Company has filed a registration statement and a prospectus supplement with the SEC to register the ADSs to be issued on
a rights basis to the existing holders of the ADSs (ADS Holders) as on the ADS Record Date by the ADS Depositary on the
basis of its Rights Entitlement for Ordinary Shares in the Issue.
Terms of Payment
Due Date
Ordinary Shares
A Ordinary Shares
On the Issue application (i.e. alongwith ` 450, which constitutes 100% of the Issue ` 271, which constitutes 100% of the Issue
the CAF)
Price payable
Price payable
17
The following tables set forth the summary financial information derived from IGAAP Financials. Our summary financial
information presented below, is in ` / ` crore and should be read in conjunction with the financial statements and the notes
(including the significant accounting principles) thereto included in Financial Statements beginning on page 92 of the Letter
of Offer.
Standalone Condensed Balance Sheet
(` in crore)
I.
3.
II.
As at December 31,
2014
2013
NON-CURRENT LIABILITIES
(a) Long-term borrowings
(b) Deferred tax liabilities (net)
(c) Other long-term liabilities
(d) Long-term provisions
CURRENT LIABILITIES
(a) Short-term borrowings
(b) Trade payables
(c) Other current liabilities
(d) Short-term provisions
TOTAL
ASSETS
1. NON-CURRENT ASSETS
(a) Fixed assets
(i)
Tangible assets
(ii) Intangible assets
(iii) Capital work-in-progress
(iv) Intangible assets under development
(b)
(c)
(d)
2.
Non-current investments
Long-term loans and advances
Other non-current assets
CURRENT ASSETS
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and bank balances
(e) Short-term loans and advances
(f) Other current assets
TOTAL
18
As at March 31,
2014
2013
643.78
15,145.52
15,789.30
643.78
19,970.72
20,614.50
643.78
18,532.87
19,176.65
638.07
18,496.77
19,134.84
13,317.26
1,125.90
1,884.62
16,327.78
9,523.01
1,203.52
1,181.06
746.45
12,654.04
9,746.45
43.11
1,155.48
815.20
11,760.24
8,051.78
1,963.91
1,238.44
691.19
11,945.32
6,910.85
8,478.82
3,108.07
1,253.62
19,751.36
51,868.44
7,902.08
7,492.99
4,483.87
976.31
20,855.25
54,123.79
4,769.08
9,672.36
2,463.18
1,892.91
18,797.53
49,734.42
6,216.91
8,455.02
4,923.10
1,509.58
21,104.61
52,184.77
12,289.29
3,732.88
1,304.30
4,570.28
21,896.75
16,962.70
2,407.76
160.89
41,428.10
12,216.59
3,218.11
1,628.82
4,189.75
21,253.27
18,239.27
3,391.84
122.28
43,006.66
12,133.50
3,107.07
1,716.85
4,638.22
21,595.64
18,357.57
2,918.30
123.85
42,995.36
12,287.71
3,168.03
1,507.84
3,244.96
20,208.54
18,171.71
3,575.24
94.32
42,049.81
622.87
4,830.96
1,523.99
1,773.89
1,570.13
118.50
10,440.34
51,868.44
2,658.13
4,302.43
1,639.95
798.88
1,598.61
119.13
11,117.13
54,123.79
100.85
3,862.53
1,216.70
226.15
1,223.77
109.06
6,739.06
49,734.42
1,762.68
4,455.03
1,818.04
462.86
1,532.09
104.26
10,134.96
52,184.77
I.
II.
III.
IV.
OTHER INCOME
TOTAL REVENUE (I + II)
EXPENSES :
(a) Cost of materials consumed
(b) Purchases of products for sale
(c) Changes in inventories of finished goods, work-inprogress and products for sale
(d) Employee cost / benefits expense
(e) Finance costs
(f) Depreciation and amortisation expense
(g) Product development expense / Engineering expense
(h) Other expenses
(i) Expenditure transferred to capital and other accounts
TOTAL EXPENSES
V.
PROFIT / (LOSS) BEFORE EXCEPTIONAL ITEMS,
EXTRA ORDINARY ITEMS AND TAX (III - IV)
VI.
EXCEPTIONAL ITEMS
(a) Exchange loss (net) including on revaluation
(b) Provision for loan given and costs associated with
closure of operations of a subsidiary
(c) Diminution in the value of investments in a subsidiary
(d) Employee separation cost
(e) Profit on sale of a division
VII. PROFIT / (LOSS) BEFORE EXTRA ORDINARY
ITEMS AND TAX (V - VI)
VIII. Extraordinary items
IX.
PROFIT / (LOSS) BEFORE TAX FROM
CONTINUING OPERATIONS (VII - VIII)
X.
Tax expense / (credit) (net)
XI.
PROFIT / (LOSS) AFTER TAX FROM CONTINUING
OPERATIONS (IX - X)
XII. EARNINGS PER SHARE
A. Ordinary shares (face value of ` 2 each)
a. Basic
b. Diluted
B.
19
(` in crore)
Year Ended
March 31,
2014
2013
37,758.00
49,319.73
(3,469.89)
(4,554.01)
34,288.11
44,765.72
3,833.03
2,088.20
38,121.14
46,853.92
15,925.82
4,112.50
(701.65)
15,474.67
3,647.52
34.61
20,492.87
5,049.82
371.72
27,244.28
5,864.45
(143.60)
2,255.26
1,103.03
1,779.89
297.18
5,899.49
(843.89)
29,827.63
(2,518.83)
2,164.68
1,014.96
1,531.01
318.81
5,150.21
(775.31)
28,561.16
866.25
2,877.69
1,337.52
2,070.30
428.74
6,987.53
(1,009.11)
38,607.08
(485.94)
2,837.00
1,387.76
1,817.62
425.76
7,783.32
(953.80)
46,262.79
591.13
299.34
-
246.09
202.00
273.06
202.00
263.12
245.00
0.13
(2,818.30)
27.03
391.13
17.52
47.28
(1,025.80)
(9.67)
(82.25)
174.93
(2,818.30)
391.13
(1,025.80)
174.93
756.40
(3,574.70)
(760.00)
1,151.13
(1,360.32)
334.52
(126.88)
301.81
(11.11)
(11.11)
3.57
3.57
1.03
1.03
0.93
0.93
(11.11)
(11.11)
3.67
3.67
1.13
1.13
1.03
1.03
A.
B.
(` in crore)
Year Ended
March 31,
2014
2013
(3,574.70)
1,151.13
334.52
301.81
1,779.89
(2.24)
310.49
1,531.01
(3.39)
6.34
2,070.30
(4.52)
20.29
1,817.62
(4.52)
2.96
(47.91)
(36.60)
-
(1,980.63)
202.00
(2,052.33)
202.00
(43.91)
(82.25)
245.00
756.40
(647.40)
269.17
2,381.80
(1,192.90)
27.03
(760.00)
(689.20)
251.87
(1,414.97)
(263.84)
17.52
(1,360.32)
(443.18)
276.90
(1,273.34)
(938.82)
5.29
(9.67)
(126.88)
(656.52)
199.39
1,346.51
1,648.32
(968.43)
(307.29)
1.14
(411.49)
(1,231.10)
(204.40)
1,198.38
(1,923.19)
(3,116.09)
(25.43)
(3,141.52)
152.60
178.09
13.70
22.46
(1,093.29)
(143.32)
220.48
(649.28)
(913.12)
(41.42)
(954.54)
592.50
601.34
15.00
141.37
1,212.83
249.25
646.05
3,458.34
2,519.52
(56.06)
2,463.46
129.42
890.28
64.76
(138.30)
(249.93)
(381.50)
188.06
502.79
2,151.11
107.33
2,258.44
(2,132.64)
9.76
(568.24)
(81.85)
(36.49)
(159.00)
-
(1,956.43)
1.70
(1,832.89)
(243.28)
(206.73)
(325.00)
-
(3,105.42)
11.37
445.63
(443.18)
(135.15)
(325.00)
-
(2,605.39)
16.95
110.00
(315.51)
(186.12)
(16.82)
(0.01)
(0.84)
21
(22.91)
290.66
-
(146.28)
297.83
-
(194.36)
0.63
1,803.90
(200.00)
0.08
(625.19)
124.92
7.32
42.41
1,682.59
5.00
(127.43)
3,608.48
(200.00)
(530.14)
230.15
124.71
1,583.75
522.07
3,978.48
(200.00)
200.00
(530.15)
760.40
181.70
1,602.68
(40.00)
2,552.91
1,378.95
21.00
10.75
(1.38)
91.25
(205.85)
780.00
404.07
1,660.65
43.53
991.50
(0.35)
(0.35)
(0.23)
(32.52)
(66.11)
(87.54)
(93.02)
7,479.33
(3,244.80)
4,715.58
(4,641.22)
1,998.23
0.09
1,629.38
(330.63)
6,795.55
(5,392.48)
121.33
(886.95)
(658.05)
(96.55)
0.09
0.16
2,310.59
2,562.84
(2,232.38) (3,377.47)
8,548.00
11,873.79
(8,679.86) (10,177.80)
(1,473.41)
1,287.75
(7.15)
(648.63)
(1,291.07)
4,327.75
1,058.80
198.68
(11.24)
1,246.24
(359.45)
(648.56)
(1,287.74)
461.03
28.56
205.57
7.26
241.39
(362.19)
(648.81)
(1,749.90)
(5,033.81)
(17.44)
205.57
10.55
198.68
(1,868.38)
(1,460.41)
(1,809.42)
(4,045.69)
(795.75)
919.64
81.68
205.57
320.63
248.77
373.78
345.06
413.34
413.34
232.83
I.
II.
ASSETS
1. NON-CURRENT ASSETS
(a) Fixed assets
(i) Tangible assets
(ii) Intangible assets
(iii) Capital work-in-progress
(iv) Intangible assets under development
(b)
(c)
(d)
(e)
(f)
TOTAL
2. CURRENT ASSETS
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and bank balances
(e) Short-term loans and advances
(f) Other current assets
TOTAL
22
(` in crore)
As at December 31,
2014
2013
As at March 31,
2014
2013
643.78
68,178.87
68,822.65
433.42
643.78
63,007.93
63,651.71
416.01
643.78
64,959.67
65,603.45
420.65
638.07
36,999.23
37,637.30
370.48
54,843.47
3,094.96
4,630.22
12,540.16
75,108.81
47,812.74
1,942.32
2,814.12
12,239.32
64,808.50
45,258.61
1,572.33
2,596.86
12,190.29
61,618.09
32,155.29
2,048.21
3,284.06
8,337.24
45,824.80
12,908.35
53,632.48
19,724.87
9,050.78
95,316.48
239,681.36
14,007.98
48,282.23
19,636.02
9,083.94
91,010.17
219,886.39
9,695.86
57,315.73
17,373.86
7,970.68
92,356.13
219,998.32
11,620.21
44,912.35
22,224.94
7,788.16
86,545.66
170,378.24
50,564.84
26,435.82
10,461.80
25,340.38
112,802.84
4,938.17
1,239.17
2,789.57
13,874.03
1,787.02
137,430.80
40,104.26
24,091.05
8,408.38
21,122.09
93,725.78
5,109.13
1,469.88
2,612.83
16,378.91
5,268.96
124,565.49
40,694.29
23,418.55
10,137.30
23,125.26
97,375.40
4,978.83
1,114.39
2,347.08
13,268.84
5,068.45
124,152.99
32,728.95
18,680.41
4,345.11
14,108.44
69,862.91
4,102.37
1,222.41
4,428.93
15,584.12
1,023.95
96,224.69
14,632.97
29,064.73
11,319.90
30,987.02
12,623.51
3,622.43
102,250.56
239,681.36
11,093.13
26,986.52
11,105.20
29,582.90
11,996.37
4,556.78
95,320.90
219,886.39
9,572.28
27,270.89
10,574.23
29,711.79
14,055.24
4,660.90
95,845.33
219,998.32
7,542.32
21,036.82
10,959.60
21,114.82
12,667.05
832.94
74,153.55
170,378.24
I.
II.
III.
IV.
V.
VI.
VII.
VIII.
IX.
X.
XI.
XII.
XIII.
XIV.
XV.
(` in crore)
OTHER INCOME
TOTAL REVENUE (I + II)
EXPENSES :
(a)
Cost of materials consumed
111,805.29 97,654.08 135,550.04 113,851.34
(b)
Purchases of products for sale
9,314.75
7,748.86 10,876.95
9,266.00
(c)
Changes in inventories of finished goods, work-in-progress (1,718.48) (2,100.29) (2,840.58) (3,029.29)
and products for sale
(d)
Employee cost / benefits expense
18,765.84
15,529.11 21,556.42 16,632.19
(e)
Finance costs
2,929.20
3,066.23
4,733.78
3,560.25
(f)
Depreciation and amortisation expense
9,531.87
7,952.68
11,078.16
7,601.28
(g)
Product development / Engineering expenses
2,063.18
1,788.63
2,565.21
2,021.59
(h)
Other expenses
35,633.54 31,934.19 43,825.77 35,648.33
(i)
Expenditure transferred to capital and other accounts
(11,406.44) (9,875.98) (13,537.85) (10,193.45)
TOTAL EXPENSES
176,918.75 153,697.51 213,807.90 175,358.24
PROFIT BEFORE EXCEPTIONAL ITEMS,
EXTRA ORDINARY ITEMS AND TAX (III - IV)
18,955.11 14,392.76 19,854.35 14,250.04
EXCEPTIONAL ITEMS
(a)
Exchange loss (net) including on revaluation of foreign
23.43
352.66
707.72
515.09
currency borrowings, deposits and loans
(b)
Provision for costs associated with closure of operations
224.16
224.16
87.62
and impairment of intangibles
(c)
Employee separation cost
0.13
53.50
(d)
Profit on sale of a division
23.56
576.82
985.38
602.71
PROFIT BEFORE EXTRA ORDINARY ITEMS
AND TAX (V - VI)
18,931.55 13,815.94 18,868.97 13,647.33
Extraordinary items
PROFIT BEFORE TAX FROM CONTINUING
18,931.55 13,815.94 18,868.97 13,647.33
OPERATIONS (VII - VIII)
Tax expense / (credit) (net)
6,619.33
3,667.86
4,764.79
3,776.66
PROFIT AFTER TAX FROM CONTINUING OPERATIONS
12,312.22 10,148.08 14,104.18
9,870.67
(IX - X)
Share of profit / (loss) of associates (net)
10.47
(36.41)
(53.71)
105.61
Minority interest
(52.90)
(38.94)
(59.45)
(83.67)
PROFIT FOR THE YEAR
12,269.79 10,072.73 13,991.02
9,892.61
EARNINGS PER SHARE
A.
Ordinary shares (face value of ` 2 each)
a.
Basic
38.11
31.34
43.51
31.02
b.
Diluted
38.10
31.33
43.50
30.94
B.
A Ordinary shares (face value of ` 2 each)
a.
Basic
38.21
31.44
43.61
31.12
b.
Diluted
38.20
31.43
43.60
31.04
23
(` in crore)
Year ended
March 31,
2014
2013
12,269.79
10,072.73
13,991.02
9,892.61
9,529.63
319.34
7,949.29
21.18
11,073.64
46.52
7,596.76
23.89
(68.35)
-
(59.04)
224.16
(114.58)
224.16
(80.09)
87.62
(127.73)
(10.47)
52.90
6,619.33
2,343.98
296.14
18,954.77
31,224.56
(104.14)
36.41
(0.41)
38.94
3,667.86
2,549.93
257.09
14,581.27
24,654.00
(154.46)
53.71
(1.05)
59.45
4,764.79
4,019.77
722.11
20,694.06
34,685.08
5.29
(138.29)
(105.61)
0.41
83.67
3,776.67
2,828.30
434.31
14,512.93
24,405.54
(2,045.48)
(840.35)
1,270.50
(1,165.41)
(3,214.39)
(717.72)
1,622.01
(5,090.84)
26,133.72
(2,612.37)
23,521.35
(2,042.04)
1,923.68
(645.24)
1,809.91
(5,002.37)
(409.27)
1,295.91
(3,069.42)
21,584.58
(2,927.53)
18,657.05
(2,852.55)
2,130.19
(67.55)
1,123.90
4,693.90
(141.66)
888.18
5,774.41
40,459.49
(4,308.33)
36,151.16
(2,655.81)
(2,697.57)
(2,479.10)
(999.03)
8,132.19
(628.33)
1,324.79
(2.86)
24,402.68
(2,240.07)
22,162.61
(23,955.45)
22.24
(5,232.87)
(160.00)
(3.76)
-
(19,292.03)
27.84
(2,179.33)
(190.45)
(3.28)
(38.00)
(26,975.13)
49.93
(424.69)
(184.56)
(3.88)
13.60
-
(18,862.57)
36.69
186.11
(0.01)
(5.50)
(107.69)
44.14
36.51
42.19
2.45
3.56
21.00
12.86
25
Year ended
March 31,
2014
2013
(237.50)
200.00
(4.48)
(251.21)
1,365.93
762.15
(5,252.38)
(6,972.22)
863.31
836.65
653.23
712.89
14.51
56.25
25.53
38.40
44.83
(29,893.02) (23,491.37)
(0.35)
(0.35)
(0.23)
(32.53)
(66.11)
(87.54)
(93.02)
(658.05)
-
(886.95)
(96.55)
0.56
15,386.77
(7,172.68)
7,310.48
(6,324.46)
2,039.51
0.09
16,190.28
(5,802.34)
10,054.13
(8,835.75)
265.54
0.09
23,321.39
(16,737.81)
11,353.56
(12,403.24)
(1,416.57)
0.16
13,160.24
(7,538.44)
14,702.92
(13,011.82)
155.56
(7.15)
(676.35)
(33.35)
(3,860.08)
6,630.16
1,551.42
(359.45)
(684.53)
(26.21)
(4,086.28)
6,649.03
1,576.14
(362.19)
(688.62)
(33.35)
(6,170.56)
(3,883.24)
2,374.90
(1,868.38)
(1,527.24)
(23.33)
(4,665.56)
(1,692.08)
(3,020.84)
16,627.98
(106.81)
18,072.59
12,350.98
41.80
2,501.68
16,470.60
12,350.97
40.51
1,861.60
16,627.98
14,849.89
521.92
12,350.97
576.69
469.72
665.93
568.49
413.34
413.34
232.83
Aggregate Value at
Issue Price
No. of
Total No. of Shares Total No. of Shares held in
Shareholders
Dematerialized Form
9
4
4
937,781,325
1,774,880
1,774,880
937,781,325
1,774,880
1,774,880
26
Total Shareholding as a %
of Total No. of Shares
As a % of
As a % of
(A+B)
(A+B+C)
43.52
0.08
0.08
34.27
0.06
0.06
61,400,000
0
0
6.55
0.00
0.00
No. of
Total No. of Shares Total No. of Shares held in
Shareholders
Dematerialized Form
Sub Total
13
939,556,205
939,556,205
(2) Foreign
Total shareholding of Promoter
and Promoter Group (A)
13
939,556,205
939,556,205
(B) Public Shareholding
(1) Institutions
Mutual Funds / UTI
271
60,789,361
60,700,631
Financial Institutions / Banks
192
4,594,987
4,288,647
Central Government / State
Government(s)
7
2,038,825
24,920
Insurance Companies
174
233,689,761
233,688,211
Foreign Institutional Investors
917
677,621,352
677,574,527
Any Others (Specify)
61
36,695,855
36,695,855
Foreign Bodies DR
3
11,018,391
11,018,391
Foreign Institutional Investors - DR
1
2,213
2,213
Foreign Nationals - DR
1
991
991
Foreign Portfolio Investor
(Corporate)
56
25,674,260
25,674,260
Sub Total
1,622
1,015,430,141
1,012,972,791
(2) Non-Institutions
Bodies Corporate
2,407
12,036,278
11,387,133
Individuals
Individual shareholders holding
nominal share capital up to Rs. 1
lakh
358,672
160,282,795
132,957,475
Individual shareholders holding
nominal share capital in excess of
Rs. 1 lakh
63
8,251,104
7,253,289
Any Others (Specify)
9,907
19,482,049
16,191,429
Non Resident Indians
9,174
10,607,845
7,319,465
Clearing Members
660
3,684,350
3,684,350
Trusts
66
4,618,305
4,616,555
Overseas Corporate Bodies
3
490
0
Foreign Corporate Bodies
4
571,059
571,059
Sub Total
371,049
200,052,226
167,789,326
Total Public shareholding (B)
372,671
1,215,482,367
1,180,762,117
Total (A)+(B)
372,684
2,155,038,572
2,120,318,322
(C) Shares held by Custodians
and against which Depository
Receipts have been issued
0
0
0
(1) Promoter and Promoter
Group
0
0
0
(2) Public
4
581,674,550
581,653,550
Sub Total
4
581,674,550
581,653,550
Total (A)+(B)+(C)
372,688
2,736,713,122
2,701,971,872
Notes:
1. For determining public shareholding for the purpose of Clause 40A.
2. For definitions of Promoter and Promoter Group, refer to Clause 40A.
27
Total Shareholding as a %
of Total No. of Shares
As a % of
As a % of
(A+B)
(A+B+C)
43.60
43.60
34.33
61,400,000
6.54
2.82
0.21
2.22
0.17
0
0
0.00
0.00
0.09
10.84
31.44
1.70
0.51
0.00
0.00
0.07
8.54
24.76
1.34
0.40
0.00
0.00
0
0
0
0
0
0
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.19
47.12
0.94
37.10
0
0
0.00
0.00
0.56
0.44
0.00
7.44
5.86
0.00
0.38
0.90
0.49
0.17
0.21
0.00
0.03
9.28
56.40
100.00
0.30
0.71
0.39
0.13
0.17
0.00
0.02
7.31
44.41
78.75
0
0
0
0
0
0
0
0
0
61,400,000
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.85
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
21.25
21.25
100.00
0
0
0
61,400,000
0.00
0.00
0.00
2.24
Name of the
Shareholder
Details of warrants
Details of convertible
securities
As a
As a % of Number of As a % Number of As a %
percentage grand total warrants
total
convertible
total
(A)+(B)+(C)
held
number of securities number of
of sub-clause
warrants
held
convertible
(I)(a)
of the same
securities
class
of the same
class
Total shares
(including
underlying
shares assuming
full conversion
of warrants
and convertible
securities) as a %
of diluted share
capital
0.00
25.66
0.00
5.54
0.00
2.50
Name of the
Shareholder
Life Insurance
Corporation of India
ICICI Prudential Life
Insurance Company
Ltd
Total
38,498,902
1.41
0.00
0.00
1.41
128,346,457
4.69
0.00
0.00
4.69
28
Nil
Total
(v) Statement showing details of DRs:
0
0
0.00
0.00
Sr. No.
1
2
0
0
0.00
0.00
0
0
Shares Underlying
Outstanding DRs as % of
Total No. of Shares
581,630,190
21.25
44,360
0.00
581,674,550
21.25
116,326,038
8,872
116,334,910
(vi) Statement showing holding of DRs, where underlying shares held by promoter / promoter group are in excess of 1% of the
total number of shares.
Sr. No.
No. of Shares
Shares Underlying
Underlying
Outstanding DRs as a % of
Outstanding DRs
Total No. of Shares
1
Nil
0.00
0.00
Total
0.00
0.00
B. A Ordinary Shareholding Pattern of our Company as per the last filing with the Stock Exchanges
(i) The A Ordinary Shareholding pattern of our Company as on December 31, 2014, is as follows:
Category of Shareholder
Type of Outstanding
DR (ADRs, GDRs,
SDRs, etc.)
Nil
No. of
Shareholders
Total No.
of Shares
4
4
2,478,587
2,478,587
2,478,587
2,478,587
0.51
0.51
0.51
0.51
0
0
0.00
0.00
2,478,587
2,478,587
0.51
0.51
0.00
122
5
2
5
227
1
16
16
378
109,844,747
1,184,596
1,445,391
3,100,048
294,667,045
298
13,472,157
13,472,157
423,714,282
109,844,747
1,184,596
1,445,391
3,100,048
294,667,045
298
13,472,157
13,472,157
423,714,282
22.79
0.25
0.30
0.64
61.14
0.00
2.80
2.80
87.91
22.79
0.25
0.30
0.64
61.14
0.00
2.80
2.80
87.91
0
0
0
0
0
0
0
0
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
29
No. of
Shareholders
Total No.
of Shares
(2) Non-Institutions
Bodies Corporate
1,052 11,847,351
11,847,166
Individuals
Individual shareholders holding nominal share capital up to
60,898 28,073,677
27,833,198
Rs. 1 lakh
Individual shareholders holding nominal share capital in
60 12,850,069
12,850,069
excess of Rs. 1 lakh
Any Others (Specify)
1,763
3,002,979
2,999,409
Non Resident Indians
1,345
1,602,735
1,599,165
Clearing Members
407
1,162,691
1,162,691
Trusts
11
237,553
237,553
Sub Total
63,773 55,774,076
55,529,842
Total Public shareholding (B)
64,151 479,488,358
479,244,124
Total (A)+(B)
64,155 481,966,945
481,722,711
(C) Shares held by Custodians and against which
0
0
0
Depository Receipts have been issued
(1) Promoter and Promoter Group
0
0
0
(2) Public
0
0
0
Sub Total
0
0
0
Total (A)+(B)+(C)
64,155 481,966,945
481,722,711
Notes:
1. For determining public shareholding for the purpose of Clause 40A
2. For definitions of Promoter and Promoter Group, refer to Clause 40A
3. Public shareholding.
(ii) Statement showing shareholding of A Ordinary Shares including shares, warrants
belonging to the category Promoter and Promoter Group as on December 31, 2014:
Sr.
No.
Name of the
Shareholder
2.46
2.46
0.00
5.82
5.82
0.00
2.67
2.67
0.00
0.62
0.33
0.24
0.05
11.57
99.49
100.00
0.00
0.62
0.33
0.24
0.05
11.57
99.49
100.00
0.00
0
0
0
0
0
0
0
0
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
100.00
0
0
0
0
0.00
0.00
0.00
0.00
Details of warrants
Details of convertible
Total shares
securities
(including
underlying
As a % of No
As a
As a % of Number As a % Number of As a % total
grand total
percentage grand total
of
total
convertible number of shares assuming
(A)+(B)+(C)
(A)+(B)+(C) warrants number securities convertible full conversion
of warrants
of sub-clause
held
of
held
securities
(I)(a)
warrants
of the same and convertible
securities) as
of the
class
a % of diluted
same
share capital
class
30
0.41
0.09
0.01
0.00
0.51
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Name of the
Shareholder
No. of
Shares as %
Shares held of Total No.
of Shares
Details of warrants
Details of convertible securities
Number of As a % total
Number of % w.r.t total number
warrants
number of
convertible
of convertible
held
warrants of securities held
securities of the
the same class
same class
5.21
0.00
5.16
0.00
0.00
5.16
4.07
0.00
0.00
4.07
3.54
0.00
0.00
3.54
3.35
0.00
0.00
3.35
3.00
0.00
0.00
3.00
2.16
2.15
0
0
0.00
0.00
0
0
0.00
0.00
2.16
2.15
1.93
0.00
0.00
1.93
1.90
0.00
0.00
1.90
1.71
0.00
0.00
1.71
1.67
0.00
0.00
1.67
1.66
0.00
0.00
1.66
1.42
0.00
0.00
1.42
1.39
0.00
0.00
1.39
1.31
0.00
0.00
1.31
1.22
0.00
0.00
1.22
1.11
0.00
0.00
1.11
1.03
0.00
0.00
1.03
44.98
0.00
0.00
44.98
31
Sl.
No.
1
5.21
0.00
0.00
5.21
5.16
10.37
0
0
0.00
0.00
0
0
0.00
0.00
5.16
10.37
Nil
Total
Nil
Shares Underlying
Outstanding DRs as % of
Total No. of Shares
0.00
0.00
(vi) Statement showing holding of DRs, where underlying shares held by Promoter / Promoter Group are in excess of 1% of the
total number of shares.
Sl.
No.
No. of Shares
Shares Underlying
Underlying
Outstanding DRs as %
Outstanding DRs
of Total No. of Shares
1 Nil
Nil
0.00
0.00
Total
0.00
0.00
2. Except as stated below, no Securities have been acquired by the Promoter or members of the Promoter Group in the year
immediately preceding the date of filing of the Letter of Offer with the Designated Stock Exchange.
(i) Ordinary Shares
Name of the Promoter / Date of the transaction Number of Ordinary Nature of the Transaction
Promoter Group entity
Shares
Tata Steel Limited
May 23, 2014
147,810,695
Acquisition pursuant to scheme of amalgamation
which received the approval of the Stock
Exchanges / SEBI on May 23, 2014
3. None of the Securities held by any of the shareholders of our Company are locked in.
4. Subscription to the Issue by the Promoter and Promoter Group
The Promoter of our Company, Tata Sons Limited, by way of its letter dated March 30, 2015 has undertaken to subscribe, on
its own account, to the full extent of its Rights Entitlement in the Issue.
Further, the Promoter has also confirmed that it will subscribe to the Rights Entitlement of, Sir Dorabji Tata Trust, Lady Tata
Memorial Trust, Sir Ratan Tata Trust and JRD Tata Trust (collectively, the Trusts), which are members of the Promoter
Group, that may be renounced in favour of the Promoter since subscription to their respective Rights Entitlement would not be
covered under the category of eligible investments under the provisions of the Bombay Public Trusts Act, 1950, as amended.
Such renunciation of the Rights Entitlement by the Trusts to the Promoter would not be considered as renunciation for
the purposes of Regulation 10(4)(b)(i) of Takeover Regulations as the Trusts are not permitted to subscribe to their Rights
Entitlement in terms of the Bombay Public Trusts Act, 1950. Such subscription by the Promoter toOrdinary Shares and A
Ordinary Sharesin this Issue to the extent of the Rights Entitlements renounced in its favour by the Trusts shall be exempt from
open offer requirements in terms of Regulation 10(4)(b) of the Takeover Regulations.
The acquisition of Securities by the Promoter and members of the Promoter Group shall not result in a change of control of the
management of our Company. Our Company is in compliance with Clause 40A of the Listing Agreement and will continue to
comply with the minimum public shareholding requirements pursuant to the Issue.
5. The ex-rights price of the Ordinary Shares and A Ordinary Shares as per regulation 10(4)(b) of the Takeover Regulations is `
550.94 and ` 346.46, respectively.
32
Particulars
Amount (in ` crore)
Gross Proceeds from the Issue
7,498.00
(Less) Issue related expenses
70.00
Net Proceeds from the Issue
7,428.00
Requirement of funds and utilisation of Net Proceeds
The proposed utilisation of the Net Proceeds is set forth in the
table below:
Particulars
Amount (in ` crore)
Funding capital expenditure towards
500.00
plant and machinery
Funding expenditure relating to
1,500.00
research and product development
Repayment, in full or part, of certain
4,000.00
long term and short term borrowings
availed by our Company
General corporate purposes
1,428.00
Total
7,428.00
Schedule of deployment
We propose to deploy the Net Proceeds for the aforesaid purposes
in accordance with the estimated schedule of implementation
and deployment of funds set forth in the table below.
(in ` crore)
Particulars
Amount
Estimated
proposed to Utilization
be funded
in Fiscal
from the Net
2016
Proceeds
Funding capital expenditure
500.00
500.00
towards plant and machinery
Funding expenditure relating
1,500.00
1,500.00
to research and product
development
Repayment, in full or part, of
4,000.00
4,000.00
certain long term and short
term borrowings availed by our
Company
General corporate purposes
1,428.00
1,428.00
Total
7,428.00
7,428.00
As indicated above, our Company proposes to deploy the entire
Net Proceeds towards the objects as described herein during
Fiscal 2016. However, if the Net Proceeds are not completely
utilised for the objects stated above by the Fiscal 2016 due to
factors such as (i) economic and business conditions; (ii) change
in competitive intensity; (iii) commercial considerations; (iv)
change in business strategy; and (v) regulatory changes, the
same would be utilised (in part or full) in Fiscal 2017 or a
subsequent period as may be determined by our Company in
accordance with applicable law.
The funds deployment, other than for repayment of certain
of our borrowings, described herein is based on management
estimates, current circumstances of our business and prevailing
market conditions. Our Company has not placed orders or
obtained quotations in respect of a substantial portion of the
33
34
R&D Expenses also consist of technical know-how expenses which include costs incurred towards various external agencies
who provide technical inputs and research and development support in specialized fields. In addition to technical support,
certain agencies provide finished components to our Company as part of their mandate once the regular production commences.
Technical know-how expenses also include costs associated with such finished components provided by the external agencies
in addition to the technical support.
In addition to the above, R&D Expenses also consist of conversion costs which include expenses incurred towards the design
engineers in the ERC.
Details of estimated expenses
Type of vehicle
Commercial vehicle
Vehicle family
Amount proposed to be
funded through Net Proceeds
(In ` crore)
Passenger vehicle
Car
Utility vehicle
Sub total
Grand total
225.00
139.00
224.00
588.00
574.00
338.00
912.00
1,500.00
Our Company proposed to deploy ` 1,500 crores out of the Net Proceeds to fund expenditure towards research and product
development as described above. Such fund requirements are solely based on internal estimates of our Company. Please see
Risk Factors The fund requirements in respect of the use of proceeds are based on management estimates and our Company
has not commissioned an independent appraisal for the use of the proceeds of this Issue. Furthermore, while our Company will
appoint a monitoring agency to monitor the use of the proceeds of this Issue, it has not entered into any definitive agreements
to use the proceeds of this Issue on page 22 of the Letter of Offer.
3. Repayment, in full or part, of certain long term and short term borrowings availed by our Company
Our Company has entered into certain financing arrangements with, inter alia, various banks/ financial institutions. For details
of our debt financing arrangements, see Financial Statements beginning on page 92 of the Letter of Offer.
Our Company proposes to utilize an estimated amount of ` 4,000 crores from the Net Proceeds towards repayment, in full
or in part, of certain loans availed by our Company without any obligation to any particular bank or financial institution. The
selection and extent of loans proposed to be repaid from our Companys loan facilities provided above, while based on the
applicable repayment schedule to be repaid in Fiscal 2016, is also and will be based on various commercial considerations
including, among others, the interest rate on the loan facility, the amount of the loan outstanding and the remaining tenor of the
loan andapplicable law governing such borrowings.
Given the nature of these borrowings and the terms of repayment, the aggregate outstanding loan amounts may vary from time
to time. In addition to the above, our Company may, from time to time, enter into further financing arrangements and draw down
funds thereunder. In such cases or in case any of the above loans are repaid or further drawn-down prior to the completion of
the Issue, our Company may utilize this component of the Net Proceeds towards repayment of such additional indebtedness.
The Net Proceeds for the above stated object may also be utilised for repayment of any such further borrowings and refinancing,
subject to a maximum utilisation of ` 4,000 crores for the stated object.
We believe that such repayment will help reduce our Companys outstanding indebtedness, debt servicing costs and our
Companys debt-equity ratio, thereby resulting in an enhanced equity base, assisting our Company in maintaining a favourable
debt-equity ratio in the near future and enable utilization of our accruals for further investment in our business growth and
expansion. In addition, we believe that this would improve our ability to raise further resources in the future to fund our
potential business development opportunities. The details of the outstanding loans proposed to be repaid from the Net Proceeds
are set out below:
35
Various
debenture
holders
Various
debenture
holders
Various
debenture
holders
State Bank
of India
State Bank
of India
State Bank
of India
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated February
28, 2014
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated February
28, 2014
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated February
28, 2014
Purpose(1)
To be utilised for
capital expenditure,
working
capital,
refinance
of
existing
debts
and other general
corporate purposes
permitted by the
RBI
for
bank
finance
To be utilised for
capital expenditure,
working
capital,
refinance
of
existing
debts
and other general
corporate purposes
permitted by the
RBI
for
bank
finance
To be utilised for
capital expenditure,
working
capital,
refinance
of
existing
debts
and other general
corporate purposes
permitted by the
RBI
for
bank
finance
To be utilised for
working capital and
general corporate
purpose
Amount
Amount
Sanctioned(1) Outstanding
as at March
25, 2015(1)
(in ` crore)
Repayment
Date /
Schedule
Amount
proposed to
repaid out
of the Net
Proceeds
(In ` crore)
300.00
300.00
Redemption 300.00
on December
1, 2015
300.00
300.00
Redemption 300.00
on June 3,
2015
300.00
300.00
Redemption 300.00
on October
30, 2015
100.00
100.00
R e p a y m e n t 100.00
on May 21,
2015
100.00
R e p a y m e n t 100.00
on May 25,
2015
100.00
R e p a y m e n t 100.00
on May 29,
2015
36
State Bank
of India
State Bank
of India
State Bank
of India
10
State Bank
of India
11
State Bank
of India
12
State Bank
of India
13
State Bank
of India
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated January 22,
2015
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated January 22,
2015
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated February
28, 2014
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated January 22,
2015
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated February
28, 2014
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated February
28, 2014
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated February
28, 2014
Purpose(1)
Amount
Amount
Sanctioned(1) Outstanding
as at March
25, 2015(1)
(in ` crore)
Repayment
Date /
Schedule
Amount
proposed to
repaid out
of the Net
Proceeds
(In ` crore)
100.00
R e p a y m e n t 100.00
on May 29,
2015
100.00
R e p a y m e n t 100.00
on May 30,
2015
200.00
R e p a y m e n t 200.00
on May 30,
2015
100.00
R e p a y m e n t 100.00
on June 1,
2015
100.00
R e p a y m e n t 100.00
on June 1,
2015
100.00
R e p a y m e n t 100.00
on June 4,
2015
100.00
R e p a y m e n t 100.00
on June 5,
2015
37
State Bank
of India
15
State Bank
of India
16
HDFC
Bank
Limited
HDFC
Bank
Limited
HDFC
Bank
Limited
Original
purchaser
- HDFC
Trustee
Company
Private
Limited
Original
purchaser
- HDFC
Trustee
Company
Private
Limited
Original
purchaser SBI Mutual
Fund
Original
purchaser Sundaram
Ultra Short
Term Fund
Original
purchaser
- HDFC
Bank
Limited
17
18
19
20
21
22
23
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated January 22,
2015
Working
Capital
Facility
Working
Capital
Consortium Agreement
dated July 28, 2009
read with Sanction
letter dated January 22,
2015
Short term loan
Sanction letter dated
June 23, 2014
Short term loan
Sanction letter dated
June 23, 2014
Short term loan
Sanction letter dated
January 20, 2015
Commercial paper
Contract note dated
February 25, 2015
Purpose(1)
Amount
Amount
Sanctioned(1) Outstanding
as at March
25, 2015(1)
(in ` crore)
Repayment
Date /
Schedule
Amount
proposed to
repaid out
of the Net
Proceeds
(In ` crore)
100.00
R e p a y m e n t 100.00
on June 10,
2015
100.00
R e p a y m e n t 100.00
on June 10,
2015
To be utilised for
working
capital
purpose only
To be utilised for
working
capital
purpose only
To be utilised for
working
capital
purpose only
-*
100.00
100.00
100.00
100.00
100.00
100.00
65.00
65.00
Repayment
on June 1,
2015
Repayment
on June 30,
2015
Repayment
on July 1,
2015
Repayment
on May 26,
2015
Commercial paper
-*
Contract note dated
February 25, 2015
35.00
35.00
R e p a y m e n t 35.00
on May 26,
2015
Commercial paper
-*
Contract note dated
February 25, 2015
100.00
100.00
R e p a y m e n t 100.00
on May 27,
2015
Commercial paper
-*
Contract note dated
February 23, 2015
100.00
100.00
R e p a y m e n t 100.00
on May 27,
2015
Commercial paper
-*
Contract note dated
March 23, 2015
300.00
300.00
R e p a y m e n t 300.00
on May 28,
2015
38
100.00
100.00
100.00
65.00
25
26
27
28
29
30
Original
purchaser
- HDFC
Bank
Limited
Original
purchaser DBS Bank
Limited
Original
purchaser State Bank
of India
Original
purchaser
- IDFC
Limited
Original
purchaser
- HDFC
Bank
Limited
Original
purchaser
- HDFC
Bank
Limited
Original
purchaser
- IDFC
Limited
Purpose(1)
Amount
Amount
Sanctioned(1) Outstanding
as at March
25, 2015(1)
(in ` crore)
Repayment
Date /
Schedule
Amount
proposed to
repaid out
of the Net
Proceeds
(In ` crore)
Commercial paper
-*
Contract note dated
March 24, 2015
200.00
200.00
R e p a y m e n t 200.00
on June 2,
2015
Commercial paper
-*
Contract note dated
March 3, 2015
100.00
100.00
R e p a y m e n t 100.00
on June 4,
2015
Commercial paper
-*
Contract note dated
March 4, 2015
200.00
200.00
R e p a y m e n t 200.00
on June 8,
2015
Commercial paper
-*
Contract note dated
July 3, 2014
100.00
100.00
R e p a y m e n t 100.00
on June 29,
2015
Commercial paper
-*
Contract note dated
January 20, 2015
100.00
100.00
R e p a y m e n t 100.00
on June 29,
2015
Commercial paper
-*
Contract note dated
January 20, 2015
100.00
100.00
R e p a y m e n t 100.00
on June 30,
2015
Commercial paper
-*
Contract note dated
July 8, 2014
100.00
100.00
R e p a y m e n t 100.00
on June 30,
2015
(1) As certified by V.C.Venkatraman & Co., through its certificate dated March 27, 2015. Further, V.C. Venkatranan & Co. has
confirmed that these borrowings have been utilised for the purposes for which they were availed, as provided in the relevant
borrowing documents.
4. General Corporate Purposes
Our Company proposes to deploy the balance Net Proceeds aggregating ` 1,428.00 crore towards general corporate purposes,
subject to such utilization not exceeding 25% of the Net Proceeds, in compliance with the SEBI Regulations, including but not
limited to strategic initiatives, partnerships and joint ventures, meeting exigencies which our Company may face in the ordinary
course of business, meeting expenses incurred in the ordinary course of business and any other purpose as may be approved
by the Board or a duly appointed committee from time to time, subject to compliance with the necessary provisions of the
Companies Act.
Our management, in accordance with the policies of the Board, will have flexibility in utilizing any amounts for general
corporate purposes under the overall guidance and policies of our Board. The quantum of utilization of funds towards any of the
purposes will be determined by the Board, based on the amount actually available under this head and the business requirements
of our Company, from time to time.
39
Activity
Expense
Amount
(in `
crore)
Percentage Percentage
of Total
of Issue
Estimated
Size (%)
Issue
Expenditure
(%)
38.28
54.68
0.51
Fees of the
G C S L M s ,
Lead Managers
and
Co-Lead
Manager
and
Underwriting
commission
2
Fees to the
13.67
19.53
0.18
legal advisors,
other
service
providers and
statutory fees
3
Fees
of
0.14
0.20
0.00
Registrar to the
Issue
4
Printing
and
4.44
6.34
0.06
s t a t i o n e r y,
distribution,
p o s t a g e ,
Advertising
and marketing
expenses etc.
5
Other expenses
13.47
19.25
0.18
Total
Estimated
70.00
100.00
0.93
Issue Expenditure
(including Service
Tax)
Interim use of Net Proceeds
Pending utilization for the objects described above, our
Company, in accordance with the policies established by our
Board from time to time, will have the flexibility to deploy the
Net Proceeds. Our Company intends to deposit the Net Proceeds
with scheduled commercial banks included in the second
schedule of the Reserve Bank of India Act, 1934. We confirm
that pending utilization of the Net Proceeds for the objects of the
Issue, our Company shall not utilize the Net Proceeds for any
investment in the equity markets, real estate or related products.
Bridge Financing Facilities
Our Company has not raised any bridge loans from any bank or
financial institution as on the date of the Letter of Offer, which
are proposed to be repaid from the Net Proceeds.
Monitoring of Utilization of Funds
Our Company has appointed HDFC Bank as the Monitoring
Agency in relation to the Issue under the requirements of
Regulation 16 of the SEBI Regulations. Our Board and
Monitoring Agency will monitor the utilization of the Net
Proceeds. Our Company will disclose the utilization of the Net
OUR MANAGEMENT
Board of Directors
Our Companys Articles of Association provides that the
minimum number of Directors shall be three. As of the date of
the Letter of Offer, our Company has ten directors, of which
two Directors are Executive Directors and six Directors are
Independent Directors. Pursuant to the provisions of the
Companies Act, 2013 at least two-thirds of the total number
of Directors excluding the Independent Directors are liable to
retire by rotation, with one-third of such number retiring at each
annual general meeting. A retiring director is eligible for reelection. Further, the Independent Directors may be appointed
for a maximum of two terms of up to five consecutive years
each. Any re-appointment of Independent Directors shall, inter
alia, be on the basis of the performance evaluation report and
approved by the shareholders by way of a special resolution.
The quorum for meetings of our Board is one-third of the total
number of Directors, or two Directors, whichever is higher,
unless otherwise fixed by the Directors.
The following table sets forth details regarding our Board as of
the date of filing the Letter of Offer:
40
Nusli N Wadia
Designation: Non-Executive Independent Director
Term: Appointed as an Independent Director with effect
from July 31, 2014 up to February 14, 2019
DIN: 00015731
Occupation: Business
Address: Beach House, P. Balu Marg, Prabhadevi, Mumbai
400 025
71
72
Nasser Munjee
Designation: Non-Executive Independent Director
Term: Appointed as an Independent Director with effect
from July 31, 2014 up to July 30, 2019
DIN: 00010180
Occupation: Professional
Address: Benedict Villa, House No. 471, Saudevado, Chorao
Island, Tiswadi Goa 403 102
62
41
Other Directorships
Other Directorships
(1) Cyrus Investments Private Limited
(2) Jaguar Land Rover Automotive Plc
(3) Sterling Investment Corporation Private Limited
(4) Tata AG, Zug
(5) Tata America International Corporation
(6) Tata Chemicals Limited
(7) Tata Consultancy Services Limited
(8) Tata Enterprises (Overseas) AG, Zug
(9) Tata Global Beverages Limited
(10) Tata Industries Limited
(11) Tata International AG, Zug
(12) Tata Limited
(13) Tata Sons Limited
(14) Tata Steel Limited
(15) The Tata Power Company Limited
(16) Tata Teleservices Limited
(17) The Indian Hotels Company Limited
Other Directorships
(1) The Bombay Dyeing & Manufacturing Company
Limited
(2) Wadia Techno-Engineering Services Limited
(3) Tata Steel Limited
(4) The Bombay Burmah Trading Corporation
Limited
(5) Tata Chemicals Limited
(6) Britannia Industries Limited
(7) Go Airlines (India) Limited
(8) Go Investments & Trading Private Limited
(9) Leila Lands SDN Bhd (Malaysia)
(10) Strategic Food International Company LLC,
Dubai, U.A.E.
(11) Strategic Brand Holdings Co. Ltd., UAE
(12) Al Sallan Food Industries Co. SAOG, Oman
(13) Al Fayafi General Trading Co. LLC, UAE
(14) Britannia and Associates (Dubai) Private Limited
Other Directorships
(1) Reliance Industries Limited
(2) Thermax Limited
(3) KPIT Technologies Limited
(4) Sakal Papers Private Limited
(5) Piramal Enterprises Limited
(6) Vyome Bioscience Private Limited
(7) Invictus Oncology Private Limited
(8) Reliance GeneMedix Plc., Ireland
Other Directorships
(1) ABB India Limited
(2) Ambuja Cements Limited
(3) Britannia Industries Limited
(4) Cummins India Limited
(5) DCB Bank Limited
(6) HDFC Limited
(7) Go Airlines (India) Limited
(8) Tata Chemicals Limited
(9) Tata Motors Finance Limited
(10) Tata Chemicals North America Inc, USA
(11) Jaguar Land Rover Automotive plc
(12) Aarusha Homes Private Limited
Vinesh K Jairath
Designation: Non-Executive Independent Director
Term: Appointed as an Independent Director with effect
from July 31, 2014 up to July 30, 2019
DIN: 00391684
Occupation: Professional
Address: 194-B, Kalpataru Horizon, S.K. Ahire Marg, Worli,
Mumbai 400 018
Dr. Ralf Speth
Designation: Non-Executive Director and Non-Independent
Director
Term: Liable to retire by rotation
DIN: 03318908
Occupation: Chief Executive Officer
Address: Kranzenhornweg 5 C, 83064 Raubling, Germany
56
Falguni S Nayar
Designation: Non-Executive Independent Director
Term: Appointed as an Independent Director with effect
from July 31, 2014 upto July 30, 2019
DIN: 00003633
Occupation: Professional
Address: Flat No. 9, Rushilla 5th Floor, Carmichael Road,
Mumbai 400 026
Ravindra Pisharody
Designation: Executive Director (Commercial Vehicles)
Term: Appointed for a period of five years with effect from
June 21, 2012, liable to retire by rotation
DIN: 01875848
Occupation: Service
Address: Hill Park Estate, Flat No. 9, 2nd Floor, Block No. 1,
AG Bell Road, Malabar Hill, Mumbai 400 006
52
Satish B Borwankar
Designation: Executive Director (Quality)
Term: Appointed for a period of five years with effect from
June 21, 2012, liable to retire by rotation
DIN: 01793948
Occupation: Service
Address: Flat No. H 22, VOILA S No. 118/3-5, Warje, Near
Cipla Hospital, Kothrud, Mumbai - Bangalore Highway,
Pune 411 052
62
59
59
42
Other Directorships
Other Directorships
(1) Tata Communications Limited
(2) Tata Steel Limited
(3) TRF Limited
(4) GlaxoSmithKline Consumer Healthcare Limited
(5) Batliboi Limited
(6) Larsen & Toubro Limited
(7) Tata Communications International Pte Ltd.
(8) Tata Communications Services (International) Pte
Ltd.
(9) SunBorne Energy Holdings LLC
Other Directorships
(1) Indiabulls Real Estate Limited
Other Directorships
(1) Jaguar Land Rover Automotive PLC
(2) Jaguar Land Rover Limited
(3) Jaguar Land Rover Holding Limited
(4) Spark44 (JV) Limited
(5) ACEA-Belgium and Brussels
(6) Bladon Jets
(7) Confederation of British Industry (CBI)
(8) Sun Catalytix Corporation
(9) Society Motors Manufacturers & Traders
Other Directorships
(1) Dabur India Limited
(2) ACC Limited
(3) FSN Ecommerce Ventures Private Limited
(4) Heritage View Developers Private Limited
(5) Valleyview Probuild Private Limited
(6) Sea View Probuild Private Limited
Other Directorships
(1) Tata Marcopolo Motors Limited
(2) Tata Cummins Private Limited
(3) Tata International Limited
(4) Tata Motors Finance Limited
(5) Automobile Corporation of Goa Limited
(6) Tata Hispano Motors Carrocera SA
(7) Tata Hispano Motors Carrocerries Maghreb SA
(8) Tata International Singapore Pte Limited
(9) Nita Company Limited
(10) Tata Motors (SA) (Pty) Limited
(11) Tata Daewoo Commercial Company Limited
(12) Tata Motors (Thailand) Limited
Other Directorships
(1) Tata Cummins Private Limited
(2) TML Drivelines Limited
(3) Tata Marcopolo Motors Limited
(4) Jaguar Land Rover India Limited
(5) TAL Manufacturing Solutions Limited
(6) Tata Motors (Thailand) Limited
(7) Tata Daewoo Commercial Vehicle Company
Limited
43
Automotive operations
Other Operations
Inter-segmenteliminations
Total
Category
Passenger Cars
Utility Vehicles
Light Commercial
Vehicles
Medium and Heavy
1,09,795 15.1
97,761 12.8
Commercial Vehicles
Total
7,28,476 100.0 7,62,695 100.0
Our automotive operations segment is further divided into
(i) Tata and other brand vehicles (including vehicle financing
thereof); and (ii) Jaguar Land Rover. During the nine months
ended December 31, 2014, Jaguar Land Rover contributed
83.4% of our total automotive revenue (before intra-segment
elimination), compared to 81.0% of total automotive revenue
(before intra-segment elimination) during the nine months ended
December 31, 2013. The remaining 16.6% of total automotive
revenue during the nine months period ended December 31,
2014 (before intra-segment elimination) was contributed by
Tata and other brand vehicles, compared to 19.0% of total
automotive revenue (before intra-segment elimination) for the
nine months ended December 31, 2013.
Revenue from Tata and other brand vehicles (including vehicle
financing thereof) and Jaguar Land Rover for nine months
ended December 31, 2014 and 2013 and the percentage change
from period to period (before intra-segment eliminations) is set
forth in the below table.
16.5
44
Category
46
Percentage to Revenue
from operations
For nine months ended
December 31,
2014
2013
100
100
61.2
61.7
9.6
9.3
Processing charges
Stores, spare parts and tools
consumed
Freight, transportation, port
charges, etc.
Repairs to buildings
Repairs to plant, machinery,
etc.
Power and fuel
Rent
Rates and taxes
Insurance
Publicity
7,748.86
(2,100.29)
1,19,401.56
1,03,302.65
47
4,847.48
81.41
346.11
57.08
181.42
807.90
383.37
256.20
202.05
6,170.02
802.93
338.46
196.32
206.08
5,919.90
11.50
35,633.54
31,934.19
48
FY 2012-13
FY 2013-14
4.5
4.6
4.4
4.4
4.5
4.7
5.2
4.6
4.6
4.7
49
Industry Sales
Company Sales
FY 2013-14 FY 2012-13 Growth FY 2013-14 FY 2012-13
Units
Units
Units
Units
Commercial vehicles
698,907
900,433
-22.4%
377,909
536,232
Passenger vehicles
2,438,502
2,557,566
-4.7%
141,846
229,325
Total
3,137,409
3,457,999
-9.3%
519,755
765,557
Source: Society of Indian Automobile Manufacturers report and Company Analysis
Commercial vehicles include V2 Van sales.
Passenger vehicles include Fiat and Jaguar Land Rover branded cars
Market Share
Growth FY 2013-14 FY 2012-13
-29.5%
-38.1%
-32.1%
54.1%
5.8%
16.6%
59.6%
9.0%
22.1%
Industry Sales
Company Sales
Market Share
FY 2013-14 FY 2012-13 Growth FY 2013-14 FY 2012-13 Growth FY 2013-14 FY 2012-13
Units
Units
Units
Units
M&HCV
200,424
267,983
-25.2%
109,984
142,764
-23.0%
54.9%
53.3%
LCV
498,483
632,450
-21.2%
267,925
393,468
-31.9%
53.7%
62.2%
698,907
900,433
-22.4%
377,909
536,232
-29.5%
54.1%
59.6%
Total
Source: Society of Indian Automobile Manufacturers report and Company Analysis
LCVs include V2 Van sales
The Companys commercial vehicle sales in the domestic and international markets at 420,992 units were 27.5% lower than the
previous year.
Even under these difficult conditions, the Company has been able to gain market share in the critical M&HCV segment. The
Company has been focusing intensely on market and customer activities to stimulate the buying sentiments. Activities included the
Prima Truck Racing Championship event in March, 2014 the first of its kind initiative in the Indian trucking history. The Prima LX
series of trucks - a combination of economy &technology - were launched in FY2013- 14 which included - 2523T, 3123T, 4028S
(Single reduction and Hub reduction) and 4928S (Single reduction and Hub reduction), 4923.S LX, Prima 4938 Tractor, 3138K
50
Industry Sales
Company Sales
Market Share
FY 2013-14 FY 2012-13 Growth FY 2013-14 FY 2012-13 Growth FY 2013-14 FY 2012-13
Units
Units
Units
Units
Micro
21,130
53,847
-60.8%
21,130
53,847
-60.8%
100.0%
100.0%
Compact
786,888
794,284
-0.9%
84,141
117,377
-28.3%
10.7%
14.8%
Midsize
154,981
200,013
-22.5%
2,414
7,410
-67.4%
1.6%
3.7%
Executive
18,272
23,537
-22.4%
164
1,061
-84.5%
0.9%
4.5%
Premium & Luxury
3,973
5,214
-23.8%
1,430
825
73.3%
36.0%
15.8%
Utility Vehicles
532,963
560,892
-5.0%
29,409
45,841
-35.8%
5.5%
8.2%
Vans
118,618
123,254
-3.8%
3,158
2,964
6.5%
2.7%
2.4%
Total
2,438,502
2,557,566
-4.7%
141,846
229,325
-38.1%
5.8%
9.0%
Source: Society of Indian Automobile Manufacturers report and Company Analysis
Note (a): excludes V2 Van sales
Note (b): Total industry nos. includes sale in other segments
During the year, the Company recorded sales of 141,846 vehicles (including Jaguar Land Rover) in the domestic market; a decline
of 38.1%. The domestic market share was 5.8% as compared to 9.0% last year.
The Company introduced a host of new products including the E-max range of CNG vehicles, Vista tech, the refreshed and improved
Sumo Gold.
Nano Awesome Campaign was launched during the year, along with the launch of Nano Twist with electronic power steering,
thereby continuing to take the Nano Brand closer to the youth.
During the Delhi Auto Expo 2014, Tata Motors Flagship products, the Bolt hatchback and the Zest Sedan were unveiled, to much
appreciation. The Companys Horizonext strategy was unveiled, showcasing the direction of Design, Performance & Connectivity
that are going to be the brand pillars going ahead. The Expo also saw the Nexon Compact SUV concept and the connectivity concept
for the Companys future cars being unveiled.
The drive to improve sales experience for customer with a focus on decor and ambience in showrooms across country continues.
The dealership network is also being augmented to cater to the demand for Bolt and Zest launch.
The Company sold 2,805 Jaguar and Land Rover vehicles through its exclusive dealerships in India registering an impressive
growth of 12.5%. The globally popular Range Rover Sport and Jaguar XF 3.0D was launched during the year. New brand touch
points were created in social media for both Jaguar and Land Rover in a short span. Besides Land Rover Experience events were
launched through which over 600 Dynamic Drive Off-road Experiences were delivered. 1st ever Land Rover Expedition was also
launched in India that received a stupendous response. A new after-sales customer engagement initiative was introduced through
Service Clinics in various dealer cities. Used Car program was introduced through 11 Outlets and achieved a 48% penetration in
March 2014.
51
FY 2013-14
FY 2012-13
Growth
%
Units
%
Units
.Jaguar
79,307 18.5% 57,812 15.5% 37.2%
Land Rover 350,554 81.5% 314,250 84.5% 11.6%
Total
429,861 100.0% 372,062 100.0% 15.5%
52
FY 2013-14
41,299.44
FY 2012-13
50,895.05
190,378.50
(76.14)
231,601.80
136,822.17
(93.31)
187,623.91
FY 2013-14
FY 2013-14
FY 2012-13
Revenue from operations net of
100
100
excise duty
Expenditure:
Cost of material consumed
61.7
63.6
(including change in stock)
Employee Cost
9.3
8.8
Manufacturing
and
other
18.8
18.9
expenses (net)
Amount Capitalised
(5.8)
(5.4)
Total Expenditure
84.0
85.9
Other Income
0.4
0.4
Profit before Exceptional Items,
16.4
14.5
Depreciation, Interest and Tax
Depreciation and Amortisation
5.9
5.1
(including product development
/ engineering
expenses written off)
Finance costs
2.0
1.9
Exceptional Item - Loss
0.4
0.3
Profit before Tax
8.1
7.2
Cost of materials consumed (including change in stock)
(` in crores)
FY 2013-14
Consumption of raw materials 135,550.04
and components
FY 2012-13
113,851.34
FY 2012-13
FY 2013-14 FY 2012-13
Processing charges
1,093.53
1,450.56
Stores, spare parts and tools
1,682.34
1,424.12
consumed
Freight, transportation, port
6,879.75
4,803.67
charges, etc.
Repairs to buildings
93.58
120.84
Repairs to plant, machinery, etc.
261.45
202.24
Power and fuel
1,128.69
1,077.77
Rent
465.86
317.55
Rates and taxes
265.51
203.07
Insurance
278.75
225.91
Publicity
8,064.10
6,607.14
Works operation and other
23,660.54
19,098.97
expenses
Excise Duty on change in Stock(48.33)
116.49
in-trade
Manufacturing and Other
43,825.77
35,648.33
Expenses
The increases are mainly driven by volumes, size of operations
and also include inflation impact however this has remained
same at 18.8% as compared to 18.9% in FY 2012-13, in terms
of % to revenue.
i. Processing charges were mainly incurred by TML, where
mainly due to volume contraction, the expenditure was
lower.
ii. Freight, transportation, port charges etc. have increased,
mainly at JLR, in view of increase in volumes in the
overseas markets.
iii. The publicity expenses increase, mainly related to new
product launches (Range Rover Sport and the F- Type
launch) and ongoing product / brand campaigns.
iv. The works operation and other expenses have increased to
10.2% from 10.1% of net revenue. While a part of revenue
relates to volumes, the major increases were in IT costs,
warranty and engineering expenses at JLR, partly offset by
exchange gain on trading activities at JLR.
Amount capitalised represents expenditure transferred to
capital and other accounts allocated out of employee cost
and other expenses, incurred in connection with product
development projects and other capital items. The expenditure
transferred to capital and other accounts has increased to
`13,537.85 crore from `10,193.45 crore of FY 2012-13, mainly
on account of various product development projects undertaken
by the Company and JLR, for introduction of new products,
development of engine and products variants.
Other Income was `828.59 crores from `815.59 crores in FY
2012-13 and mainly includes interest income of `675.45 crores
(FY 2012-13 ` 694.06 crores) and profit on sale of investment of
`114.58 crores (FY 2012-13 `80.09 crores). The increase is due
Exchange loss
(net) including on
revaluation of foreign
currency borrowings,
deposits and loans
Impairment of
224.16
87.62 136.54
intangibles and other
costs
Employee separation
53.50
53.50
cost
Total
985.38
602.71 382.67
i. Foreign exchange loss (net) represents impact on account
of revaluation of foreign currency borrowings, deposits
and loans, and amortisation of loss / gain, on such foreign
currency monetary items which was deferred in previous
years.
ii. Impairment of intangibles and other costs are in respect
of subsidiary companies, triggered by continuous under
performance, mainly attributed by challenging market
conditions in which the subsidiaries operate.
iii. Employee separation cost -To address the challenges,
business downturn, the Company had rolled out
organization wide cost optimization programme, which
included employee cost as an important pillar, Accordingly,
based on requests from employees for early retirement,
the Company has given early retirement with a lump sum
amount of `53.50 crores to various employees.
Consolidated Profit Before Tax (PBT) increased to `18,868.97
crores in FY 2013-14, compared to `13,647.33 crores in FY
2012-13, representing an increase of `5,221.64 crores. Due to
severe contraction in domestic volumes, TMLs contribution
to PBT was negative. JLR by virtue of its strong performance,
contributed to PBT. The increase also includes translation
impact.
56
Sales / Turnover
Other Income
Total Income
Estimated gross profit / loss (excluding depreciation and taxes)
Provision for depreciation
Provision for taxes (net)
Estimated Net Profit / (Loss)
Material changes and commitments, if any, affecting our financial position
There are no material changes affecting the financial position of our Company after the last date of the financial statements included
in the Letter of Offer.
MATERIAL DEVELOPMENTS
In addition to the discussions in Managements Discussion and Analysis of Financial Conditions and Results of Operations
beginning on page 93 of the Letter of Offer, the following are the material developments in respect of our operations, performance,
prospects or profitability, or the value of our assets or our ability to pay material liabilities since April 1, 2014.
Trading Update
Our total sales (including exports) of Tata Motors vehicles in January and February 2015 were 42,582 vehicles and 44,209 vehicles
respectively, representing increases of 5% and 11% over the sales in January and February 2014. However, on a cumulative basis,
as of February 28, 2015, we had sold only 449,659 vehicles for the Fiscal 2015, as compared to 515,407 vehicles in the equivalent
period in the fiscal year ended March 31, 2014, representing a decline of 13%.
The table below sets forth the breakdown in sales of Tata Motors vehicles for the periods indicated.
Category
January
2014
% change
11,637
176
11,813
8,463
353
8,816
38%
-50%
34%
1,410
71
1,481
2,511
84
2,595
14,301
2,291
16,592
17,517
2,317
19,834
2015
Passenger Cars
Domestic
Exports
Subtotal
Utility Vehicles
Domestic
Exports
Subtotal
Light Commercial Vehicles
Domestic
Exports
Subtotal
57
February
2014
% change
11,805
120
11,925
9,026
339
9,365
31%
-65%
27%
-44%
-15%
-43%
1,962
49
2,011
2,299
100
2,399
-15%
-51%
-16%
-18%
-1%
-16%
14,357
2,584
16,941
14,881
2,850
17,731
-4%
-9%
-4%
2015
Uttarakhand plant
1. Application dated October 10, 2014 made to the Assistant
Director of Factories, Haldwani for renewal of factory
license for the year 2015.
OTHER REGULATORY AND STATUTORY
DISCLOSURES
Authority for the Issue
The Issue has been authorised by a resolution of our Board
passed at its meetings held on (a) January 27, 2015 pursuant to
Section 62 of the Companies Act, 2013; and (b) March 25, 2015.
Further, the issue of A Ordinary Shares has also been authorised
by a resolution dated March 3, 2015 of the shareholders of our
Company passed through postal ballot in terms of Rule 4(1)(b)
of the Companies (Share Capital and Debentures) Rules, 2014.
The Issue Price of ` 450 for the Ordinary Shares and ` 271 for
A Ordinary Shares has been arrived at in consultation with the
GCSLMs, the Lead Managers and the Co-Lead Manager.
Our Company has received approvals from the BSE and the
NSE under Clause 24(a) of the Listing Agreement for listing of
the Securities to be allotted in the Issue pursuant to letters, dated
March 27, 2015.
RBI Approval for Renunciation
The RBI has, pursuant to a letter dated March 30, 2015,
conveyed its no-objection to renunciation of Rights Entitlement
by the following:
1. resident shareholder to a non-resident. The offer price
to NR should not be less than at which the offer is made
to a resident shareholder in terms of Regulation 6 of
Notification No. FEMA.20/2000-RB dated May 3, 2000,
as amended from time to time. Further the renunciation of
the Rights Entitlement should be on the floor of the Stock
Exchanges;
2. non-resident shareholder to a resident on the floor of the
Stock Exchanges; and
3. non-resident shareholder to a non-resident on the floor of
the Stock Exchanges. However the offer price to NR should
not be less than at which the offer is made to a resident
shareholder. If the non-resident shareholder renouncing
the Rights Entitlement includes FIIs, the individual
limit and the over all limits (as applicable) would have
to be complied with; subject to the condition that: (a)
the Company complies with all the documentation and
reporting requirements; (b) if any transaction involves an
erstwhile OCB, the bank should approach with full details
for prior approval; (c) the NRI Shareholders holding nonrepatriable shares may renounce the Rights Entitlement in
favour of residents or other NRIs only; and (d) in terms
of Regulation 6 of Notification No. FEMA 20/2000-RB
dated May 3, 2000 as amended from time to time, only
the existing non-resident Shareholders may subscribe for
additional Securities over and above the Securities offered
on the rights basis by the Company.
Accordingly, only the following may apply for additional
Securities in the Issue:
(i) resident Ordinary Shareholders and A Ordinary
Shareholders of our Company;
(ii) non-resident Ordinary Shareholders and A Ordinary
Shareholders of our Company subject to the sectoral
cap; and
(iii) resident Renouncees.
Prohibition by SEBI or Other Governmental Authorities
Our Company, the Promoter, the members of the Promoter
61
62
(3)
(4)
(5)
(6)
(7)
(8)
63
Eligible Shareholders
Colour of the
CAF
Eligible Ordinary Shareholders
White
Eligible A Ordinary Shareholder
Yellow
Each of the Ordinary Shares CAF and the A Ordinary Shares
CAF consists of four parts:
Part A: Form for accepting the Securities (Ordinary Shares or
A Ordinary Shares, as the case may be) offered as a part of this
Issue, in full or in part, and for applying for additional Ordinary
Shares or A Ordinary Shares, as applicable;
Part B: Form for renunciation of Securities (Ordinary Shares or
A Ordinary Shares, as the case may be);
Part C: Form for application of Securities (Ordinary Shares or
A Ordinary Shares, as the case may be) by Renouncee(s);
Part D: Form for request for split application forms.
Please note that Eligible Shareholders can apply for
Ordinary Shares only through an Ordinary Shares CAF (or
plain paper) and for A Ordinary Shares only through A
Ordinary Shares CAF (or plain paper). Please also note that
Renouncees can apply for Ordinary Shares only through
Ordinary Shares CAF and for A Ordinary Shares only
through A Ordinary Shares CAF.
Option available to the Eligible Shareholders
Ordinary Shares CAFs will be issued to Eligible Ordinary
Shareholders.
The Ordinary Shares CAFs will clearly indicate the number
of Ordinary Shares that the Eligible Ordinary Shareholder is
entitled to.
An Eligible Ordinary Shareholder can:
1. Apply for his Rights Entitlement of Ordinary Shares in
full;
2. Apply for his Rights Entitlement of Ordinary Shares in
part;
3. Apply for his Rights Entitlement of Ordinary Shares in part
and renounce the other part of the Ordinary Shares;
4. Apply for his Rights Entitlement in full and apply for
additional Ordinary Shares;
5. Renounce his Rights Entitlement in full.
A Ordinary Shares CAFs will be issued to Eligible A Ordinary
Shareholders.
The A Ordinary Shares CAF will clearly indicate the number of
A Ordinary Shares that the Eligible A Ordinary Shareholder
is entitled to.
An Eligible A Ordinary Shareholder can:
1. Apply for his Rights Entitlement of A Ordinary Shares in
full;
2. Apply for his Rights Entitlement of A Ordinary Shares in
part;
3. Apply for his Rights Entitlement of A Ordinary Shares in
part and renounce the other part of the A Ordinary Shares;
4. Apply for his Rights Entitlement in full and apply for
additional A Ordinary Shares;
5. Renounce his Rights Entitlement in full.
Acceptance of the Issue
You may accept the offer to participate and apply for the
Ordinary Shares or A Ordinary Shares, as applicable, offered,
70
Government Route and with the prior approval of the RBI if the
investment is through the automatic route on case by case basis.
Shareholders renouncing their rights in favour of OCBs may do
so provided such Renouncee obtains a prior approval from the
RBI. On submission of such approval to us at our Registered
Office, the OCB shall receive the Abridged Letter of Offer and
the CAF.
Part A of the CAF must not be used by any person(s) other
than those in whose favour this offer has been made. If used,
this will render the application invalid. Submission of the CAF
to the Bankers to the Issue at its collecting branches specified
on the reverse of the CAF with the form of renunciation (Part
B of the CAF) duly filled in shall be the conclusive evidence
for our Company of the fact of renouncement to the person(s)
applying for Securities in Part C of the CAF for the purpose
of Allotment of such Securities. The Renouncees applying for
all the Securities renounced in their favour may also apply for
additional Securities. Part A of the CAF must not be used by
the Renouncee(s) as this will render the application invalid.
Renouncee(s) will have no right to further renounce any
Securities in favour of any other person.
Procedure for renunciation
The following procedure applies to renunciation of the Ordinary
Shares and A Ordinary Shares, as the case may be:
To renounce all the Securities offered to an Eligible Shareholder
in favour of one Renouncee
If you wish to renounce the offer indicated in Part A, in whole,
please complete Part B of the CAF. In case of joint holding,
all joint holders must sign Part B of the CAF. The person in
whose favour renunciation has been made should complete and
sign Part C of the CAF. In case of joint Renouncees, all joint
Renouncees must sign Part C of the CAF.
To renounce in part/or renounce the whole to more than one
person(s)
If you wish to either (i) accept the offer in part and renounce
the balance, or (ii) renounce the entire offer under this Issue in
favour of two or more Renouncees, the CAF must be first split
into requisite number of forms. Please indicate your requirement
of SAFs in the space provided for this purpose in Part D of the
CAF and return the entire CAF to the Registrar so as to reach
them latest by the close of business hours on the last date of
receiving requests for SAFs as provided herein. On receipt of
the required number of SAFs from the Registrar, the procedure
as mentioned in paragraph above shall have to be followed.
In case the signature of the Eligible Shareholder(s), who has
renounced the Securities, does not match with the specimen
registered with our Company/ Depositories, the application is
liable to be rejected.
Renouncee(s)
The person(s) in whose favour the Ordinary Shares or A
Ordinary Shares, as the case may be, are renounced should fill
in and sign Part C of the Ordinary Shares CAF or A Ordinary
Shares CAF, as the case may be, and submit the entire Ordinary
Shares CAF or A Ordinary Shares CAF, as the case may be,
to the Bankers to the Issue or any of the collection branches as
mentioned on the reverse of the Ordinary Shares CAF or A
Ordinary Shares CAF, as the case may be, on or before the Issue
Closing Date along with the application money in full.
Change and/or introduction of additional holders
If you wish to apply for Ordinary Shares or A Ordinary Shares,
as the case may be, jointly with any other person(s), not more
than three including you, who is/are not already a joint holder
with you, it shall amount to renunciation and the procedure as
stated above for renunciation shall have to be followed. Even
71
3.
Sr.
No.
Option Available
Action Required
Fill in and sign Part A (All
joint holders must sign in
the same sequence)
Fill in and sign Part
A including Block III
relating to the acceptance
of entitlement and Block
IV relating to additional
Ordinary Shares or A
Ordinary Shares, as the
case may be (All joint
holders must sign in the
same sequence)
Fill in and sign Part D (all
joint holders must sign
in the same sequence)
requesting for SAFs. Send
the CAF to the Registrar
so as to reach them on or
before the last date for
receiving requests for
SAFs. Splitting will be
permitted only once.
On receipt of the SAF
take action as indicated
below.
(i) For the Ordinary
Shares
or
A
Ordinary Shares, as
the case may be, you
wish to accept, if any,
fill in and sign Part A.
4.
Renounce
your
Rights
Entitlement in full to one
person (Joint Renouncees
are considered as one).
5.
Action Required
(ii) For the Ordinary
Shares
or
A
Ordinary Shares, as
the case may be, you
wish to renounce, fill
in and sign Part B
indicating the number
of Ordinary Shares or
A Ordinary Shares,
as the case may
be, renounced and
hand it over to the
Renouncees.
(iii) Each
Renouncee
should fill in and
sign Part C for the
Ordinary Shares or
A Ordinary Shares,
as the case may be,
accepted by them.
Fill in and sign Part B (all
joint holders must sign
in the same sequence)
indicating the number of
Ordinary Shares or A
Ordinary Shares, as the
case may be, renounced
and hand it over to
the Renouncee. The
Renouncee must fill in
and sign Part C (all joint
Renouncees must sign)
This will be treated as
renunciation. Fill in
and sign Part B and the
Renouncee must fill in
and sign Part C.
which may occur after the date of the Letter of Offer. Investors
who are eligible to apply under the ASBA Process are advised
to make their independent investigations and to ensure that the
CAF is correctly filled up.
The GCSLMs, the Lead Managers, the Co-Lead Manager, our
Company, its directors, its employees, affiliates, associates
and their respective directors and officers and the Registrar
to the Issue shall not take any responsibility for acts,
mistakes, errors, omissions and commissions etc. in relation
to applications accepted by SCSBs, Applications uploaded by
SCSBs, applications accepted but not uploaded by SCSBs or
applications accepted and uploaded without blocking funds in
the ASBA Accounts. It shall be presumed that for applications
uploaded by SCSBs, the amount payable on application has
been blocked in the relevant ASBA Account.
Please note that in accordance with the provisions of
the SEBI circular no. CIR/CFD/DIL/1/2011 dated April
29, 2011 all QIBs, Non-Institutional Investors and NonRetail Individual Investors complying with the eligibility
conditions prescribed under the SEBI circular no. SEBI/
CFD/DIL/ASBA/1/2009/30/12 dated December 30, 2009
must mandatorily invest through the ASBA process. All
Retail Individual Investors complying with the conditions
prescribed under the SEBI circular dated December 30,
2009 may optionally apply through the ASBA process.
The Investors who are not (i) QIBs, (ii) Non-Institutional
Investors, or (iii) Investors whose Application Money is more
than ` 200,000, can participate in the Issue either through
the ASBA process or the non ASBA process. Renouncees
and Eligible Shareholders holding Ordinary Shares or A
Ordinary Shares in physical form are not eligible ASBA
Investors and must only apply for Securities through the
non-ASBA process, irrespective of the Application Money.
All non-retail Investors are encouraged to make use of
ASBA process wherever such facilities is available.
Please note that subject to SCSBs complying with the
requirements of SEBI Circular No. CIR/CFD/DIL/13/2012
dated September 25, 2012 within the periods stipulated
therein, ASBA Applications may be submitted at all
branches of the SCSBs.
Further, in terms of the SEBI circular CIR/CFD/DIL/1/2013
dated January 2, 2013, it is clarified that for making applications
by banks on own account using ASBA facility, SCSBs should
have a separate account in own name with any other SEBI
registered SCSB(s). Such account shall be used solely for
the purpose of making application in public/rights issues and
clear demarcated funds should be available in such account
for ASBA applications. SCSBs applying in the Issue using the
ASBA facility shall be responsible for ensuring that they have a
separate account in its own name with any other SCSB having
clear demarcated funds for applying in the Issue and that such
separate account shall be used as the ASBA Account for the
application, in accordance with the applicable regulations.
The list of banks which have been notified by SEBI to act as
SCSBs for the ASBA Process is provided on http://www.sebi.
gov.in/sebiweb/home/list/5/33/0/0/Recognised-Intermediaries.
For details on Designated Branches of SCSBs collecting the
CAF, please refer the above mentioned SEBI link.
Eligible Shareholders who are eligible to apply under the
ASBA Process
The option of applying for Securities in the Issue through the
ASBA Process is only available to the Eligible Shareholders of
our Company on the Book Closure Date and who:
1. hold the Securities in dematerialised form as on the Book
Closure Date and have applied towards his/her Rights
75
Underwriters Commitments
(In ` crore)
Ordinary
A
Total
Shares Ordinary
Shares
615
75
690
Underwriting
fees
(%)
Citigroup Global
0.75
Markets India Private
Limited
Credit Suisse
615
75
690
0.75
Securities India Private
Limited
DSP Merrill Lynch
615
75
690
0.75
Limited
HSBC Securities and
615
75
690
0.75
Capital Markets (India)
Private Limited
J.P Morgan India
615
75
690
0.75
Private Limited
ICICI Securities
310
40
350
0.50
Limited
Kotak Mahindra
310
40
350
0.50
Capital Company
Limited
SBI Capital Markets
310
40
350
0.50
Limited
HDFC Bank Limited
0.22
0.03
0.25
0.50
TOTAL
4,005.22
495.03 4,500.25
Note: The obligations of each Underwriter mentioned above are
several and not joint.
The Underwriting Agreement also provides that if an
Underwriter defaults, then the purchase amounts of nondefaulting Underwriters may be increased or the offering may
be terminated.
In the opinion of the Board of Directors, the resources of the
Underwriters are sufficient to enable them to discharge their
underwriting obligations in full.
Our Company has agreed that, for a period of 90 days from the
date of listing of the Securities, our Company will not, without
the prior written consent of the Underwriters, issue any Securities
or any securities convertible into or exercisable or exchangeable
for the Securities or publicly announce any intention to do so
during the aforesaid period. However, our Company may, issue
securities on account of conversion of financial instruments
outstanding as of March 30, 2015 in connection with the Issue.
The Promoter has also agreed that, in case of devolvement on
the Underwriter in excess of 40% of the Securities offered in
the Issue, it shall not, for a period of 90 days from the date of
listing of the Securities offered in the Issue, without the prior
written consent of the Underwriters, (a) directly or indirectly,
sell or otherwise transfer or dispose of any Ordinary Shares or
A Ordinary Shares held by the Promoter as of the date of the
listing of the Securities (the Locked-in Shares) or publicly
announce an intention with respect to any of the foregoing; (b)
enter into any swap or any other agreement or any transaction
that transfers, in whole or in part, directly or indirectly, any
85
10. The (i) audit reports each dated May 29, 2014 on the audited
standalone financial statements and audited consolidated
financial statements of our Company for Fiscal 2014, and
(ii) reports each dated February 5, 2015 on the audited
standalone financial statements for the nine months ended
December 31, 2014 and limited reviewed consolidated
financial statements for the nine months ended December
31, 2014.
11. Annual Reports of our Company for Fiscal 2014, 2013,
2012, 2011 and 2010 taken on a standalone and consolidated
basis.
12. The tax benefits statement dated March 30, 2015 from the
Statutory Auditor.
13. Approvals dated March 27, 2015 issued by BSE and NSE,
respectively under Clause 24(a) of the Listing Agreement.
14. Due Diligence Certificate dated March 30, 2015 addressed
to SEBI from the GCSLMS, the Lead Managers and the
Co-Lead Manager.
15. Tripartite Agreement dated December 9, 1997 between our
Company, the Registrar to the Issue and NSDL.
16. Tripartite Agreement dated September 27, 1999 between
our Company, the Registrar to the Issue and CDSL.
Any of the contracts or documents mentioned in the Letter of
Offer may be amended or modified at any time if so required in
the interest of our Company or if required by the other parties,
without reference to the Eligible Shareholders, subject to
compliance with applicable law.
ADDITIONAL INFORMATION
For certain additional information included in the Letter of
Offer, refer Additional Information on page 198 of the Letter
of Offer.
87
Signature
Cyrus P Mistry
Chairman and Nominee Director
Nusli N Wadia
Independent Director
Dr. Raghunath A Mashelkar
Independent Director
Nasser Munjee
Independent Director
Subodh Bhargava
Independent Director
Vinesh K Jairath
Independent Director
Dr. Ralf Speth
Non-Executive Director
Falguni S Nayar
Independent Director
Ravindra Pisharody
Executive Director (Commercial Vehicles)
Satish B Borwankar
Executive Director (Quality)
Date: March 30, 2015
Place: Mumbai
________________________
C. Ramakrishnan
Chief Financial Officer
88